REGENERON PHARMACEUTICALS, INC.

Official Publications Regeneron Pharmaceuticals, Inc.

Equities

REGN

US75886F1075

Market Closed - Nasdaq Other stock markets 16:00:00 2024-04-29 EDT			5-day change	1st Jan Change
892.5 ^USD	+1.05%		-0.85%	+1.62%

04-26	Regeneron Faces Q1 Seasonality Despite Eylea HD Launch, Oppenheimer Says	MT
04-26	Oppenheimer Adjusts Price Target on Regeneron Pharmaceuticals to $1,175 From $1,125	MT

Official Publications

SEC Filing 10K	02-04	CO
SEC Filing 8K	02-01	CO
Slide show results	02-01	CO
Annual results	02-01	CO
SEC Filing 8K	01-30	CO
SEC Filing 8K	11-01	CO
3rd quarter results	11-01	CO
SEC Filing 10Q-3	11-01	CO
Slide show Q3	11-01	CO
Slide show half-year results	23-08-02	CO
1st-half-year results	23-08-02	CO
SEC Filing 10Q-2	23-08-02	CO
SEC Filing 8K	23-05-03	CO
Slide show Q1	23-05-03	CO
SEC Filing 10Q-1	23-05-03	CO
1st quarter results	23-05-03	CO
Proxy Statments	23-04-20	CO
Annual ESG Report	23-04-20	CO
SEC Filing 10K	23-02-05	CO
SEC Filing 8K	23-02-02	CO
Slide show results	23-02-02	CO
Annual results	23-02-02	CO
SEC Filing 13G	23-01-10	CO
3rd quarter results	22-11-02	CO
Slide show Q3	22-11-02	CO

1 2

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer